(Q84571224)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19763757%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

title

One-year results of intravitreal ranibizumab for neovascular age-related macular degeneration and clinical responses of various subgroups (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19763757%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference

Seungbum Kang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19763757%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Young-Jung Roh

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19763757%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

publication date

1 July 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19763757%20AND%20SRC:MED&resulttype=core&format=json

Japanese Journal of Ophthalmology

7 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19763757%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

volume

53

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19763757%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19763757%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

page(s)

389-395

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19763757%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10384-009-0670-y

7 February 2020

exact match

0 references

cites work

The association of cardiovascular disease with the long-term incidence of age-related maculopathy

1 reference

12 December 2020

Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration: TAP and VIP report no. 1.

1 reference

12 December 2020

Ranibizumab versus verteporfin for neovascular age-related macular degeneration.

1 reference

12 December 2020

Intravitreal bevacizumab for treatment of neovascular age-related macular degeneration: a one-year prospective study.

1 reference

12 December 2020

Targeting angiogenesis, the underlying disorder in neovascular age-related macular degeneration

1 reference

12 December 2020

The role of vascular endothelial growth factor in ocular health and disease

1 reference

12 December 2020

Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degeneration

1 reference

12 December 2020

Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER Study year 1

1 reference

12 December 2020

Pegaptanib for neovascular age-related macular degeneration

1 reference

12 December 2020

Ranibizumab for predominantly classic neovascular age-related macular degeneration: subgroup analysis of first-year ANCHOR results

1 reference

12 December 2020

An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration

1 reference

12 December 2020

Placental growth factor, a member of the VEGF family, contributes to the development of choroidal neovascularization

1 reference

12 December 2020

Ranibizumab for neovascular age-related macular degeneration

1 reference

12 December 2020

Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor

1 reference

12 December 2020

Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therap

1 reference

12 December 2020

Cardiovascular risk factors and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study

1 reference

12 December 2020

Cardiovascular risk factors and age-related macular degeneration: the Los Angeles Latino Eye Study

1 reference

12 December 2020

1 reference

12 December 2020

Incidence and clinical patterns of polypoidal choroidal vasculopathy in Korean patients.

1 reference

12 December 2020

Intravitreal bevacizumab in the treatment of neovascular age-related macular degeneration, 6- and 9-month results

1 reference

12 December 2020

Basic fibroblast growth factor and vascular endothelial growth factor are present in epiretinal and choroidal neovascular membranes

1 reference

12 December 2020

Clinical characteristics of exudative age-related macular degeneration in Japanese patients.

1 reference

12 December 2020